Vitamin D and the elderly

Clinical Endocrinology

Volumn 62, Issue 3, 2005, Pages 265-281

  Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

AGING; ATHEROSCLEROSIS; BONE TURNOVER; BREAST CANCER; CALCIUM INTAKE; COLON CANCER; FALLING; GERIATRIC PATIENT; HIP FRACTURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MUSCLE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE VALUE; REVIEW; SEASONAL VARIATION; SECONDARY HYPERPARATHYROIDISM; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; FRACTURES, BONE; HUMANS; MALE; NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 15044347795     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02226.x     Document Type: Review

References (178)

1. 3 is probably much higher than what is officially recommended for adults. Journal of Steroid Biochemistry and Molecular Biology, 89-90, 575-579.
2. Holick, M.F. (1999) Vitamin D: photobiology, metabolism, mechanism of action and clinical application. In: M.J. Favus ed. Primer on the Metabolic Bone Diseases and Mineral Metabolism, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, 92-98.
3. Holick, M.F. (2003) Evolution and function of vitamin D. Recent Results in Cancer Research, 164, 3-28.
4. 3. Biochemistry, 7, 3317-3322.
5. Fraser, D.R. & Kodicek, E. (1970) Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature, 228, 764-766.
6. Leheste, J.R., Melsen, F., Wellner, M., Jansen, P., Schlichting, U., Renner-Müller, I., Andreassen, T., Wolf, E., Bachmann, S., Nykjaer, A. & Wilnow, T. (2003) Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. The FASEB Journal, 17, 247-249.
7. Brown, A.J., Dusso, A. & Slatopolsky, E. (1999) Vitamin D. American Journal of Physiology. Renal Physiology, 277, 46, F157-F175.
8. 3 with intestinal mucosa chromatin in vivo. Journal of Biological Chemistry, 243, 4055-4064.
9. 3. Steroids, 67, 457-466.
10. 3 in vivo and in vitro. Molecular Endocrinology, 18, 2660-2671.
11. 3 receptor in the immune system. Archives of Biochemistry and Biophysics, 374, 334-338.
12. Krall, E.A., Sahyoun, N., Tannenbaum, S., Dallal, G.E. & Dawson-Hughes, B. (1989) Effect of vitamin D intake on seasonal variations in parathyroid secretion in postmenopausal women. New England Journal of Medicine, 321, 1777-1783.
13. Brot, C., Vestergaard, P., Kolthoff, N., Gram, J., Herman, A.P. & Sørensen, O.H. (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. British Journal of Nutrition, 86, S97-S103.
14. Parfitt, A. & M. (1998) Osteomalacia and related disorders. In: L.V. Avioli, S.M. Krane eds. Metabolic Bone Diseases and Clinically Related Disorders. Academic Press, San Diego, 327-386.
15. Lips, P. (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews, 22, 477-501.
16. Zehnder, D., Bland, R., Williams, M.C., McNinch, R.W., Howie, A.J., Steward, P.M. & Hewison, M. (2001) Extrarenal expression of 25-hydroxyvitamin D3-1alphahydroxylase. Journal of Clinical Endocrinology and Metabolism, 86, 888-894.
17. Tangpricha, V., Flanagan, J.N., Whitlatch, L.W., Tseng, C.C., Chen, T.C., Holt, P.R., Lipkin, M.S. & Holick, M.F. (2001) 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet, 357, 1673-1674.
18. 3-1alpha- hydroxylase expression in normal and pathological parathyroid glands. Journal of Clinical Endocrinology and Metabolism, 87, 2967-2972.
19. Glerup, H., Mikkelsen, K., Poulsen, L., Hass, E., Overbeck, S., Thomsen, J., Charles, P. & Eriksen, E.F. (2000) Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. Journal of Internal Medicine, 247, 260-268.
20. Iqbal, S.J., Kaddam, I., Wassif, W., Nichol, F. & Walls, J. (1994) Continuing clinically severe vitamin D deficiency in Asians in the UK (Leicester). Postgraduate Medical Journal, 70, 708-714.
21. Iqbal, S.J., Featherstone, S., Kaddam, I.M.S., Mortimer, J. & Manning, D. (2001) Family screening is effective in picking up undiagnosed Asian vitamin D deficient subjects. Journal of Human Nutrition and Dietetics, 14, 371-376.
22. Shaw, N.J. & Pal, B.R. (2002) Vitamin D deficiency in UK Asian families: activation of new concern. Archives of Disease in Childhood, 86, 147-149.
23. Rejnmark, L., Jorgensen, M.E., Pedersen, M.B., Hansen, J.C., Heickendorff, L., Lauridsen, A.L., Mulvad, G., Siggaard, C., Skjoldborg, H., Sørensen, T.B., Pedersen, E.B. & Mosekilde, L. (2004) Vitamin D insufficiency in Greenlanders on a westernized fare. Ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcified Tissue International, 74, 255-263.
24. Awumey, E.M., Mitra, D.A. & Hollis, B.W. (1998) Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research study. Journal of Clinical Endocrinology and Metabolism, 83, 169-173.
25. Toss, G., Almqvist, S., Larsson, L. & Zetterqvist, H. (1980) Vitamin D deficiency in welfare institutions for the aged. Acta Medica Scandinavica, 208, 87-89.
26. Dawson-Hughes, B., Harris, S.S., Krall, E.A. & Dallal, G.E. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New England Journal of Medicine, 337, 670-676.
27. Flicker, L., Mead, K., McInnis, R., Nowson, C., Scherer, S., Stein, M., Thomas, J., Hopper, J. & Wark, J. (1999) Association between vitamin D, falls and fractures in older women in residential care in Australia. Journal of the American Geriatrics Society, 47, 1195-1201.
28. Holick, M.F., Matsuoka, L.Y. & Wortsman, J. (1989) Age, vitamin D, and solar ultraviolet radiation. Lancet, 4, 1104-1105.
29. Lau, K.-H.W. & Baylink, D.J. (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcified Tissue International, 65, 295-306.
30. Muhe, L., Lulseged, S., Mason, K.E. & Simoes, E.A.F. (1997) Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet, 349, 1801-1804.
31. Chan, T.Y.K. (2000) Vitamin D deficiency and susceptibility to tuberculosis. Calcified Tissue International, 66, 476-478.
32. 3 and periodontal disease in the US population. American Journal of Clinical Nutrition, 80, 108-113.
33. The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplementation in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 42, 51-54.
34. Stene, L.C., Ulriksen, J., Magnus, P. & Joner, G. (2000) Use of cod liver oil during pregnancy is associated with lower risk of type 1 diabetes in the offspring. Diabetologia, 43, 1093-1098.
35. Hyppönen, E., Laara, E., Reunanen, A., Jarvelin, M.R. & Virtanen, S.M. (2001) Intake of vitamin D and intake of type 1 diabetes: a birth cohort study. Lancet, 358, 1500-1503.
36. Stene, L.C. & Joner, G. (2003) Use of cod liver oil during the first year of life is associated with a lower risk of childhood-onset type 1 diabetes: a large population based case control study. American Journal of Clinical Nutrition, 78, 1128-1134.
37. Merlino, L.A., Curtis, J., Mikuls, T.R., Cerhan, J.R., Criswell, L.A. & Saag, K.G. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis and Rheumatism, 50, 72-77.
38. Podolsky, D.K. (1991) Inflammatory bowel disease. New England Journal of Medicine, 324, 928-1016.
39. Jahnsen, J., Falch, J.A., Mowinckel, Z.P. & Aadland, E. (2002) Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 37, 192-197.
40. Lamb, E.J., Wong, T., Smith, D.J., Simpson, D.E., Coakley, A.J., Moniz, C. & Muller, A.F. (2002) Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 16, 1895-1902.
41. Hayes, C.E. (2000) Vitamin D: a natural inhibitor of multiple sclerosis. Proceedings of the Nutrition Society, 59, 531-535.
42. Van der Mei, I.A., Ponsonby, A.L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B.V., Butzkueven, H. & Kilpatrick, T. (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case control study. British Medical Journal, 327, 216.
43. Mosekilde, L., Hermann, A.P., Beck-Nielsen, H., Charles, P., Nielsen, S.P. & Sorensen, O.H. (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2016 normal perimenopausal women. Maturitas, 31, 207-209.
44. Dawson-Hughes, B., Dallal, G.E., Krau, E.A., Harris, S., Sokol, L.J. & Falconer, G. (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Annals of Internal Medicine, 115, 505-512.
45. Ooms, M.E. (1994) Osteoporosis in elderly women: vitamin D deficiency and other risk factors. PhD Thesis, Vrije University, Amsterdam.
46. Ooms, M.E., Lips, P., Roos, J.C., van der Vijgh, W.J.F., Poop-Snijders, C., Bezemer, P.D. & Bouter, L.M. (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. Journal of Bone and Mineral Research, 10, 1177-1184.
47. Chapuy, M.C., Preziosi, P., Maamer, M., Arnaud, S., Galan, P., Hercberg, S. & Meunier, P.J. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International, 7, 439-443.
48. Guillemant, J., Taupin, P., Le, H.T., Taright, N., Allemandou, A., Peres, G. & Guillemant, S. (1999) Vitamin D status during puberty in French healthy male adolescents. Osteoporosis International, 10, 222-225.
49. Jesudason, D., Need, A.G., Horowitz, M., O'Loughlin, P.D., Morris, H.A. & Nordin, B.E. (2002) Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone, 31, 626-630.
50. Vieth, R., Ladak, Y. & Walfish, P.G. (2003) Age-related changes in the 25-hydroxyvitamm D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism, 88, 185-191.
51. Malabanan, A., Veronikis, I.E. & Holick, M.F. (1998) Redefining vitamin insufficiency. Lancet, 351, 805-806.
52. Glerup, H. (1999) Investigations on the role of vitamin D in muscle function - A study of muscle function in vitamin D deficient humans and the effect of treatment with vitamin D. PhD Thesis, Aarhus University, Denmark.
53. Jongen, M.J.M., van der Vijgh, W.J.F., Berensteyn, E.C.H., van der Berg, H., Bosch, R., Hoogenboezem, T., Visser, T.J. & Netelenbos, J.C. (1982) Interlaboratory variation of vitamin D metabolite measurements. Journal of Clinical Chemistry and Clinical Biochemistry, 20, 753-756.
54. Lips, P., Chapuy, M.C., Dawson-Hudges, B., Pols, H.A.P. & Holick, M.F. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis International, 9, 394-397.
55. Baker, M.R., McDonnall, H., Peackok, M. & Nordin, B.E. (1997) Plasma 25-hydroxyvitamin D concentrations in patients with fractures of the femoral neck. British Medical Journal, 1, 589.
56. Lips, P., van Ginkel, F.C., Jongen, M.J.M., Rubertus, A., van der Vijgh, W.J.F. & Netelenbos, J.C. (1987) Determinants of vitamin D status in patients with hip fracture and elderly control subjects. American Journal of Clinical Nutrition, 46, 1005-1010.
57. Center, J.R., Nguyen, T.V., Sambrook, P.N. & Eisman, J.A. (2000) Hormonal and biochemical parameters and osteoporotic fractures in elderly men. Journal of Bone and Mineral Research, 15, 1405-1411.
58. Larsen, E.R. (2002) Fall and fractures among elderly community residents: risk factors and prevention. PhD Thesis, Faculty of Health Sciences, University of Aarhus, Denmark.
59. Egsmose, C., Lund, B., McNair, P., Lund, B., Storm, T. & Sorensen, O.H. (1987) Low serum levels of 25-dihydroxyvitamin D in institutionalized old people: influence of solar exposure and vitamin D supplementation. Age and Ageing, 16, 35-40.
60. Lund, B., Sørensen, O.H., Lund, B., Melsen, F. & Mosekilde, L. (1982) Vitamin D metabolism and osteomalacia in patients with fractures of the proximal femur. Acta Orthopedica Scandinavica, 53, 251-254.
61. Aaron, J.E., Gallagher, J.C., Anderson, J., Stasiak, L., Longton, E.B., Nordin, B.E.C. & Nicholson, M. (1974) Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet, 1, 229-233.
62. Hoikka, V., Alhava, E.M., Savolainen, K. & Parvianinen, M. (1982) Osteomalacia in fractures of the proximal femur. Acta Orthopedica Scandinavica, 53, 255-260.
63. Hordon, L.D. & Peacock, M. (1990) Osteomalacia and osteoporosis in femoral neck fracture. Journal of Bone and Mineral Research, 11, 247-259.
64. Lips, P., Netelenbos, J.C., Jongen, M.J., van Ginkel, P.C., Althuis, A.L., van Schaik, C.L., van der Vijgh, W.J., Vermeiden, J.P. & van der Meer, C. (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metabolic Bone Disease and Related Research, 4, 85-93.
65. Von Knorring, J., Slätis, P., Weber, Th. & Helenius, T. (1982) Plasma levels of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in Southern Finland. Clinical Endocrinology, 17, 189-194.
66. Bischoff, H.A., Stahelin, H.B., Tyndall, A. & Theiler, R. (2000) Relationship between muscle strength and vitamin D metabolites: are there therapeutic possibilities in the elderly? Zeitschrift für Rheumatologie, 29 (Suppl 1), 39-41.
67. Chapuy, M.C., Durr, F. & Chapuy, P. (1983) Age-related changes in parathyroid hormone and 25 hydroxy-cholecalciferol levels. Journal of Gerontology, 38, 19-22.
68. Stein, M.S., Wark, J.D., Scherer, S.C., Walton, S.L., Chick, P., Di Carlantonio, M., Zajac, J.D. & Flicker, L. (1999) Falls related to vitamin D and parathyroid hormone in an Australian nursing home and hostel. Journal of the American Geriatrics Society, 47, 195-201.
69. Pfeifer, M., Begerow, B., Minne, H.W., Schlotthauer, T., Pospeschill, M. & Scholz, M. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Experimental and Clinical Endocrinology and Diabetes, 109, 87-92.
70. Pfeifer, M., Begerow, B., Minne, H.W., Nachtigall, D. & Hansen, C. (2001) Effect of short-term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. Journal of Clinical Endocrinology and Metabolism, 86, 1633-1637.
71. Dhesi, J.K., Bearne, L.M., Moniz, C., Hurley, M.V., Jackson, S.H., Swift, C.G. & Allain, T.J. (2002) Neuromuscular and psychomotor function in elderly people who fall and the relationship with vitamin D status. Journal of Bone and Mineral Research, 17, 891-897.
72. Sørensen, O.H., Lund, B., Saltin, B.J., Lund, R.B., Andersen, L., Hjorth, F., Melsen, F. & Mosekilde, L. (1979) Myopathy in bone loss of ageing: improvement by treatment with 1-α-hydroxycholecalciferol and calcium. Clinical Science, 56, 157-161.
73. 3 and muscle strength in the elderly in a randomised controlled trial. Journal of Clinical Endocrinology and Metabolism, 73, 1111-1117.
74. Boland, R. (1986) Role of vitamin D in skeletal muscle function. Endocrine Reviews, 7, 433-438.
75. Pfeifer, M., Begerow, B. & Minne, H.W. (2002) Vitamin D and muscle function. Osteoporosis International, 13, 187-194.
76. 3 receptors and action in muscle. Journal of Biological Chemistry, 260, 8882-8891.
77. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology, 119, 2214-2220.
78. Rodman, J.S. & Baker, T. (1978) Changes in the kinetics of muscle contraction in vitamin D depleted rats. Kidney International, 13, 189.
79. Pointon, J.J., Francis, M.J. & Smith, R. (1979) Effect of vitamin D deficiency on sarcoplasmatic reticulum function and troponin C concentrations of rabbit skeletal muscle. Clinical Science, 57, 257-263.
80. 3 on phosphate accumulation by myoblasts. Hormone and Metabolic Research, 23, 113-116.
81. Boland, R., de Boland, A.R., Ritz, E. & Hasselbach, W. (1983) Effect of 1,25-dihydroxycholecalciferol on sarcoplasmic reticulum calcium transport in strontium fed chicken. Calcified Tissue International, 35, 190-194.
82. Joborn, C., Rastad, J., Stalberg, E., Akerstrom, G. & Ljunghall, S. (1989) Muscle function in patients with primary hyperparathyroidism. Muscle and Nerve, 12, 87-94.
83. Garber, A.J. (1983) Effect of parathyroid function on skeletal muscle protein and amino acid metabolism in the rat. Journal of Clinical Investigation, 71, 1806-1821.
84. Graafmans, W.C., Ooms, M.E., Hofstee, H.M., Bezemer, P.D., Bouter, L.M. & Lips, P. (1996) Falls in the elderly: a prospective study of risk factors and risk profiles. American Journal of Epidemiology, 143, 1129-1136.
85. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal, 326, 469-475.
86. Latham, N.K., Anderson, C.S., Lee, A., Bennet, D.A., Moseley, A. & Cameron, I.D. for the Fitness Collaborative Group (2003) A randomised, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: The frailty intervention trial in elderly subjects (FITNESS). Journal of the American Geriatric Society, 51, 291-299.
87. Pfeifer, M., Begerow, B., Minne, H.W., Abrams, C., Nachtigall, D. & Hansen, C. (2000) Effects of a short term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. Journal of Bone and Mineral Research, 15, 1113-1118.
88. Bischoff, H.A., Stähelin, H.B., Dick, W., Akos, R., Knecht, M., Salis, C., Nebiker, M., Theiler, R., Pfeifer, M., Begerow, B., Lew, R.A. & Conzelmann, M. (2003) Effect of vitamin D and calcium supplementation on falls: a randomized controlled study. Journal of Bone and Mineral Research, 18, 343-351.
89. Harwood, R.H., Sahota, O., Gaynor, K., Masud, T. & Hosking, D.J. (2004) The Nottingham Neck of Femur (NONOF) study. Age and Ageing, 33, 45-51.
90. Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y. & Wong, J.B. (2004) Effect of vitamin D on falls: a meta-analysis. The Journal of the American Medical Association, 291, 1999-2006.
91. Sahota, O., Masud, T., San, P. & Hoskin, D.J. (1999) Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clinical Endocrinology, 51, 217-221.
92. Dawson-Hughes, B., Harris, S.S., Krall, E.A. & Dallal, G.E. (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. American Journal of Nutrition, 72, 745-750.
93. Johnell, O., Gullberg, B., Kanis, J.A., Allander, E., Elffors, L., Dequecker, J., Dilsen, G., Gennari, C., vas Lopez, A. & Lyritis, G. (1995) Risk factors for hip fracture in European women: the MEDOS study, Mediterranean Osteoporosis Study. Journal of Bone and Mineral Research, 10, 1802-1815.
94. Cooper, C., McLaren, M., Wood, P.J., Coulton, L. & Kanis, J.A. (1989) Indices of calcium metabolism in women with hip fractures. Bone and Mineral, 5, 193-200.
95. Boonen, S., Vanderschueren, D., Cheng, X.G., Verbeke, G., Dequecker, J., Geusens, P., Broos, P. & Bouillon, R. (1997) Age related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D and androgen deficiency induced bone resorption. Journal of Bone and Mineral Research, 12, 2119-2126.
96. 3 and calcium to prevent hip fractures in elderly women. New England Journal of Medicine, 372, 1637-1642.
97. Chapuy, M.C., Arlot, M.E., Delmas, P.D. & Meunier, P.J. (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. British Medical Journal, 308, 1081-1082.
98. Chapuy, M.C., Pamphile, R., Paris, E., Kempf, C., Schlicting, M., Arnaud, S., Garnero, P. & Meunier, P.J. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis International, 13, 257-264.
99. Gillespie, W.J., Avenell, A., Henry, D.A., O'Connell, D.L. & Robertson, J. (2003) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review) I. The Cochrane Library, issue 1. Update Software, Oxford.
100. Meyer, H.E., Smedshaug, G.B., Kvaavik, E., Falch, J.A., Tverdal, A. & Pedersen, J.I. (2002) Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomised controlled trial. Journal of Bone and Mineral Research, 17, 709-715.
101. Heikinheimo, R.J., Inkovaara, J.A., Harju, E.J., Haavisto, M.V., Kaarela, R.H., Kataja, J.M., Kokko, A.M., Kolho, L.A. & Rajala, S.A. (1992) Annual injection of vitamin D and fractures of aged bones. Calcified Tissue International, 51, 105-110.
102. Lips, P., Graafmans, W.C., Ooms, M.E., Bezemer, P.D. & Bouter, L.M. (1996) Vitamin D supplementation and fracture incidence in elderly persons. Annals of Internal Medicine, 124, 400-406.
103. Larsen, E.R., Mosekilde, L. & Foldspang, A. (2004) Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. Journal of Bone and Mineral Research, 19, 370-378.
104. Smith, H., Anderson, F., Raphael, H., Crozier, S. & Cooper, C. (2004) Effect of annual intramuscular vitamin D supplementation on fracture risk: population-based, randomised, double-blind, placebo-controlled trial. Osteoporosis International, 15, S8 (Abstract).
105. Van den Bernd, G.J. & Chang, G.T. (2002) Vitamin D and vitamin D analogues in cancer treatment. Current Drug Targets, 3, 85-94.
106. Krishnan, A.V., Peehl, D.M. & Feldman, D. (2003) Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression. Journal of Cellular Biochemistry, 88, 363-371.
107. Zittermann, A. (2003) Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition, 89, 552-572.
108. Pinette, K.V., Yee, Y.K., Amegadzie, B.Y. & Nagpal, S. (2003) Vitamin D receptor as a drug discovery target. Mini Reviews in Medicinal Chemistry, 3, 193-204.
109. Guyton, K.Z., Kensler, T.W. & Posner, G.H. (2003) Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutrition Reviews, 61, 227-238.
110. Garland, C.F. & Garland, F.C. (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology, 9, 227-231.
111. Garland, F.C., Garland, C.F., Gorham, E.D. & Young, J.F. (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Preventive Medicine, 19, 614-622.
112. Lipkin, M., Newmark, H., Boone, C.W. & Kelloff, G.J. (1991) Calcium, vitamin D and colon cancer. Cancer Research, 51, 3069-3070.
113. Garland, C.F., Garland, F.C. & Gorham, E.D. (1999) Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Annals of the New York Academy of Sciences, 889, 107-119.
114. Hanchette, C.L. & Schwartz, G.G. (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer, 70, 2861-2869.
115. Freedman, D.M., Dosemeci, M. & McGlynn, K. (2001) Sunlight and mortality from breast, ovarian, colon, prostate and non-melanoma skin cancer: a composite death certificate based case control study. Journal of Occupational and Environmental Medicine, 59, 257-262.
116. Grant, W.B. (2002) An estimate of premature cancer mortality in the US due to inadequate doses of ultraviolet solar radiation. Cancer, 94, 1867-1875.
117. Grant, W.B. (2002) An ecologic study on dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer, 94, 272-281.
118. Grant, W.B. (2003) Ecologic studies of solar UV-B radiation and cancer mortality. Recent Results in Cancer Research, 164, 371-377.
119. Grant, W.B. (2004) A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. European Urology, 45, 271-279.
120. Gorham, E.D., Garland, F. & Garland, C. (1990) Sunlight and breast cancer incidence in USSR. International Journal of Epidemiology, 19, 820-824.
121. 3-1alfa-hydroxylase activity and regulation of side chain metabolism. Journal of Steroid Biochemistry and Molecular Biology, 62, 21-28.
122. 3 inhibits proliferation of colonic epithelial cells in subjects at high risk for colon neoplasia. Gastroenterology, 118, A276.
123. Garland, C., Shekelle, R.B., Barrett-Connor, E., Criqui, M.H., Rossof, A.H. & Oglesby, P. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in man. Lancet, 1, 307-309.
124. Garland, C.F., Garland, F.C. & Gorham, E.D. (1991) Can colon cancer incidence and death rates be reduced with calcium and vitamin D? American Journal of Clinical Nutrition, 54, 193S-210S.
125. Garland, C.F., Comstock, G.W., Garland, F.C., Helsing, K.J., Shaw, E.K. & Gorham, E.D. (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2, 1176-1178.
126. McCulough, M.L., Robertson, A.S., Rodriguez, C., Jacobs, A.J., Chao, A., Jonas, C., Calle, E.E., Willett, W.C. & Thun, M.J. (2003) Calcium, vitamin D, dietary products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes and Control, 14, 1-12.
127. 3. Cancer Epidemiology, Biomarkers and Prevention, 7, 391-395.
128. Whitlatch, L.W., Young, M.V., Schwartz, G.G., Flanagan, J.N., Burnstein, K.L., Lokeshwar, B.L., Rich, E.S., Holick, M.F. & Chen, T.C. (2002) 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. Journal of Steroid Biochemistry and Molecular Biology, 81, 135-140.
129. Chen, T.C., Wang, L., Whitlatch, L.W., Flanagan, J.N. & Holick, M.F. (2003) Prostatic 25-hydroxyvitamin D-1alfa-hydroxylase and its implication in prostate cancer. Journal of Cellular Biochemistry, 88, 315-322.
130. 3 inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology, Biomarkers and Prevention, 9, 265-270.
131. Peehl, D.M., Krishnan, A.V. & Feldman, D. (2003) Pathways mediating the growth-inhibitory actions of vitamin D in prostatic cancer. Journal of Nutrition, 133, 2461S-2469S.
132. Taylor, J.A., Hirvonen, A., Watson, M., Pittman, G., Mohler, J.L. & Bell, D.A. (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Research, 56, 4108-4110.
133. Ahonen, M.H., Tenkanen, L., Teppo, L., Hakama, M. & Tuoimaa, P. (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes and Control, 11, 847-852.
134. Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Statin, P., Harvei, S., Hakulinen, T., Luostarinen, T., Dillner, J., Lehtinen, M. & Hakama, M. (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal nested case-control study in the Nordic countries. International Journal of Cancer, 108, 104-108.
135. Welsh, J., Wietzke, J.A., Zinser, G.M., Byrne, B., Smith, K. & Narvaez, C.J. (2003) Vitamin D-3 receptor as a target for breast cancer prevention. Journal of Nutrition, 133, 2425S-2433S.
136. Koga, M., Eisman, J.A. & Sutherland, R.L. (1988) Regulation of epidermal growth factor receptor level by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Research, 48, 2734-2739.
137. 3 on the morphology of human breast cancer cell line B.T.20. Differentiation, 40, 63-69.
138. John, E.M., Schwartz, G.G., Dreon, D.M. & Koo, J. (1999) Vitamin D and breast cancer risk: the NHANESI epidemiological follow-up study, 1971-1975 to 1992. National health and nutrition examination study. Cancer Epidemiology, Biomarkers and Prevention, 8, 399-406.
139. Shin, M.H., Holmes, M.D., Hankinson, S.E., Wu, K., Colditz, G.A. & Willet, W.C. (2002) Intake of dietary products, calcium, and vitamin D and risk of breast cancer. Journal of the National Cancer Institute, 94, 1301-1311.
140. Ortlepp, J.R., Lauscher, J., Hoffmann, R., Hanrath, P. & Joost, H.G. (2001) The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabetic Medicine, 18, 842-845.
141. Norman, A.W., Frankel, B.J., Heldt, A.M. & Grodsky, G.M. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 209, 823-825.
142. Boucher, B.J. (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? British Journal of Nutrition, 79, 315-327.
143. Zemmel, M.B., Hang, S., Greer, B., Dirienzo, D. & Zemel, P.C. (2000) Regulation of adiposity by dietary calcium. The FASEB Journal, 14, 1132-1138.
144. Nyomba, B.L., Bouillon, R. & DeMoor, P. (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology, 115, 191-197.
145. 3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology, 119, 84-90.
146. Gedik, O. & Akalin, S. (1986) Effects of vitamin D deficiency and repletion on insulin and glucagons secretion in man. Diabetologia, 29, 142-145.
147. Pietschmann, P., Schernthaner, G. & Woloszczuk, W. (1988) Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia, 31, 892-895.
148. Isaia, G., Giorgino, R. & Adami, S. (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care, 24, 1496.
149. 3 supplementation on cardiovascular risk factors in elderly adults. European Journal of Clinical Nutrition, 49, 640-646.
150. Ishii, H., Suzuli, H., Baba, T., Nakamura, K. & Watanabe, T. (2001) Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care, 24, 1503.
151. 2D after UV-B irradiation in healthy adults. Hormone and Metabolic Research, 21, 154-155.
152. 3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. International Journal of Clinical Practice, 57, 258-261.
153. Chiu, K.C., Chu, A., Go, V.L.W. & Saad, M.F. (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. American Journal of Clinical Nutrition, 79, 820-825.
154. Carnevale, V., Romagnoli, E. & D'Erasmo, E. (2004) Skeletal involvement in patients with diabetes mellitus. Diabetes/Metabolism Research and Reviews, 20, 196-204.
155. 3 in regulating myocardial metabolism: physiological and pathological actions. Cell Calcium, 9, 285-292.
156. Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R. & Stehle, P. (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology, 41, 105-112.
157. 3 levels: a community-based study. International Journal of Epidemiology, 19, 559-563.
158. Douglas, A.S., Rawles, J.M., Alexander, E. & Allan, T.M. (1991) Winter pressure in hospital medical beds. British Medical Journal, 303, 508-509.
159. Hegarty, V., Woodhause, P. & Khaw, K.T. (1994) Seasonal variation in 25-hydroxyvitamin D and parathyroid hormone concentrations in elderly people. Age and Ageing, 23, 478-482.
160. Rostand, S.G. (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension, 30, 150-156.
161. Resnick, L.M., Muller, F.B. & Laragh, J.H. (1986) Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Annals of Internal Medicine, 105, 649-654.
162. McCarron, D.A., Morris, C.D. & Bukoski, R. (1987) The calcium paradox of essential hypertension. American Journal of Medicine, 82, 27-33.
163. Strazzullo, P. (1991) The renal leak in primary hypertension: pathophysiological aspects and clinical implications. Nutrition, Metabolism, and Cardiovascular Diseases, 1, 98-103.
164. MacGregor, G.A. & Cappucio, F.P. (1993) The kidney and essential hypertension: a link to osteoporosis? Journal of Hypertension, 11, 781-785.
165. Nemere, I., Zhou, L.X. & Norman, A.W. (1993) Nontranscriptional effects of steroid hormones. Receptor, 3, 277-291.
166. 3 and its relation to physical activity and other heart disease risk factors in the general population. Annals of Epidemiology, 2, 697-703.
167. Pan, W.H., Wang, C.Y. & Li, L.A. (1993) No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese. Chinese Journal of Physiology, 36, 85-94.
168. Scragg, R., Holdaway, I., Singh, V., Metcalf, P., Baker, J. & Dryson, E. (1995) Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Research and Clinical Practice, 27, 181-188.
169. Lind, L., Wengle, B. & Ljunghall, S. (1987) Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double blind placebo controlled study. Acta Medica Scandinavica, 222, 423-427.
170. Lind, L., Lithell, H., Skarfors, E., Wide, L. & Ljunghall, S. (1988) Reduction of blood pressure by treatment with alfacalcidiol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Medica Scandinavica, 223, 211-427.
171. Krause, R., Buhring, M., Hopfenmühller, W., Holick, M.F. & Sharma, A.M. (1998) Ultraviolet B and blood pressure. Lancet, 352, 709-710.
172. Danish Institute for Food and Veterinary Research (2004) Vitamin D status in the Danish population should be improved. (In Danish with English summary.) Available online at: http://www.netboghandel.dk or http://www.dfvf.dk.
173. Blank, S., Scanlon, K.S., Sinks, T.H., Lett, S. & Falk, H. (1995) An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. American Journal of Public Health, 85, 656-659.
174. Scanlon, K.S., Blank, S., Sinks, T., Lett, S., Mueller, P., Freedman, D.S., Serdula, M. & Falk, H. (1995) Subclinical health effects in a population exposed to excess vitamin D in milk. American Journal of Public Health, 85, 1418-1422.
175. Holick, M.F., Shao, Q., Liu, W.W. & Chen, T.C. (1992) The vitamin D content of fortified milk and infant formula. New England Journal of Medicine, 326, 1178-1181.
176. Scientific Committee on Food (2002) Opinion of the Scientific Committee on Food on the tolerable upper intake level of vitamin D. Scientific Committee on Food, The European Commission, Brussels.
177. Vieth, R.W. (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. American Journal of Clinical Nutrition, 69, 842-856.
178. Stephens, W.P., Klimiuk, P.S., Berry, J.L. & Mawer, E.B. (1981) Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet, 28, 1199-1202.